Login

Componenta as an Investment - Investor Day 28.11.2022| Sami Sivuranta , CEO of Componenta 00:10:00

Share On Facebook Share On Twitter

Sami Sivuranta is President/CEO/IR at Componenta OYJ.

Recent Videos

00:10:00
Dryden Gold Secures $20M+ War Chest, Delivers High-Grade Discoveries and Expands Drill Targets Across Gold Rock District|Trey Wasser,CEO & Director,Dryden Gold
00:10:00
Mitchell Services Targets $50–60M EBITDA as Rig Utilization Drives Earnings Upside| Andrew Elf,CEO,Mitchell Services Limited
00:10:00
Lomiko Metals Reports Strong Pre-Feasibility Results with $800M NPV, Advancing High-Growth Graphite Projects|Gordana Slepcev,CEO,Lomiko Metals Inc.4
00:10:00
Generative AI Meets Wet Lab: Absci Accelerates Biologic Development with Hybrid Business Model|Sean McClain,CEO,Absci
00:10:00
Obliva Aims to Transform Lives of Children with Rare Mitochondrial Disorders|Ellen K. Donnelly ,CEO,Abliva AB7
00:10:00
Abionic Repositions Bio-HDL Therapy CCR001 for Rare Kidney and Eye Disorders with Promising Early Results|Cyrille Tupin,CEO,ABIONYX Pharma
00:10:00
Abingdon Health Reports 45% H1 Revenue Growth Amid Strategic Expansion and Large Contract Wins|Dr Chris Hand,Chairman,Abingdon Health
00:10:00
EB-101 Gene Therapy Shows Promising Results in Treating Recessive Dystrophic EB|Vishwas Seshadri,CEO,Abeona Therapeutics
00:10:00
Revolutionizing Trauma Care: How AAP’s Silver Technology is Fighting Deadly Implant Infections|Rubino Di Girolamo,CEO,aap Implantate AG
00:10:00
Revolutionizing Cancer Treatment: Tumor-Agnostic mTOR Targeting Shows Breakthrough Success in Rare and Genetic-Driven Tumors| Neil Desai, Founder, Executive Chairman ,Aadi Bioscience
00:10:00
Millions Affected, No Approved Cure: 89bio Advances New Therapy for NASH|Rohan Palekar,CEO,89bio Inc2
00:10:00
Malaria Prevention Drug Arakoda Positioned to Drive Future Growth for 60 Degrees Pharmaceuticals|Geoffrey Dow,President,60 Degrees Pharmaceuticals
00:10:00
4DMedical Revolutionizes Lung Imaging with CTVQ: Turning a Simple CT Scan into Functional Lung Diagnostics|Dr Andreas Fouras,CEO,4Dmedical Ltd
00:10:00
4DMedical Revolutionizes Lung Imaging with CTVQ: Turning a Simple CT Scan into Functional Lung Diagnostics|Dr Andreas Fouras,CEO,4Dmedical Ltd
00:10:00
4basebio CEO Heikki Lanckriet Unveils Vision for Next-Generation Synthetic DNA and Gene Therapy Components|Heikki Lanckriet,CEO,4basebio
00:10:00
Jim Woody on Leading 180 Life Sciences: Advancing Breakthrough Biologic Therapies for Inflammation, Fibrosis, and Pain|Dr. Jim Woody,CEO,180 Life Sciences

Suggestions

00:10:00
"Mastering Active Fund Management: Insights from Paul Glover of NFU Mutual | Paul Glover - Chief Investment Manager, NFU Mutual"
00:10:00
Parsons Corp. CEO Charles Harrington discusses the company's milestone as the first defense firm to go public on "Squawk on the Street."
00:10:00
A Conversation with Christian Sinding on Investment Strategies and Market Dynamics | Christian Sinding, CEO, EQT Partners.
00:10:00
Exploring Gold Potential in Brazil: Cabral Gold's Path to Growth
00:10:00
Gold Hits New Highs: Should You Buy or Wait?
00:10:00
Bystronic's image video encapsulates its commitment to supporting customers with passion through innovative technologies and services, shaping the future of sheet metal processing.|Alex Waser is CEO of Bystronic AG
00:10:00
Exploring Gluco's Digital Health Platform and Commercial Expansion
00:10:00
Paul Singer, Founder and President of Elliott Management Corporation, discusses investment insights with WSJ's Gerard Baker at the WSJDLive conference in Laguna.|Paul Singer, Founder and President of Elliott Management Corporation
00:10:00
Understanding Different Types of Financial Advisors and Their Fiduciary Duties
00:10:00
Understanding CAPM and Portfolio Diversification: Insights from Yale’s Financial Markets Course | Yale University - Online Learning by Coursera
00:10:00
Q2 2022 Financial Insights & Strategies
00:10:00
Key Insights on Real-Time Data and Water Management from Industry Professionals

© 2017 - Neuhu+